Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
Clinical trial NCT06806579 · RECRUITING
Trial details
- NCT number
- NCT06806579
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-21
- Primary completion
- 2030-10-31
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.